GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » AIM Vaccine Co Ltd (HKSE:06660) » Definitions » Cyclically Adjusted PS Ratio

AIM Vaccine Co (HKSE:06660) Cyclically Adjusted PS Ratio : (As of May. 06, 2025)


View and export this data going back to 2022. Start your Free Trial

What is AIM Vaccine Co Cyclically Adjusted PS Ratio?

AIM Vaccine Co does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.

Shiller PE for Stocks: The True Measure of Stock Valuation


AIM Vaccine Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for AIM Vaccine Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AIM Vaccine Co Cyclically Adjusted PS Ratio Chart

AIM Vaccine Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial - - - - -

AIM Vaccine Co Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of AIM Vaccine Co's Cyclically Adjusted PS Ratio

For the Biotechnology subindustry, AIM Vaccine Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AIM Vaccine Co's Cyclically Adjusted PS Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, AIM Vaccine Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where AIM Vaccine Co's Cyclically Adjusted PS Ratio falls into.


;
;

AIM Vaccine Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

AIM Vaccine Co does not have a history long enough to calculate Cyclically Adjusted Revenue per Share. Therefore GuruFocus does not calculate Cyclically Adjusted PS Ratio for this company.


AIM Vaccine Co  (HKSE:06660) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


AIM Vaccine Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of AIM Vaccine Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


AIM Vaccine Co Business Description

Traded in Other Exchanges
N/A
Address
91 Jianguo Road, 25th Floor, Building A, Chaoyang, Beijing, CHN
AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain ranging from research and development to manufacturing and commercialization. The Vaccine products include Recombinant HBV Vaccines, Freeze-dried Human Rabies Vaccine, Inactivated HAV Vaccines, Group A, C, Y, and W135 MPSV, Bivalent Inactivated HFRS Vaccine, and Mumps Vaccine. It generates all of its revenues in the PRC.
Executives
Shang Hai Xun Jing Qi Ye Guan Li Zhong Xin You Xian He Huo 2201 Interest of corporation controlled by you
Xi Zang Ying Feng Shi Ye You Xian Gong Si 2101 Beneficial owner
Yang Aihua 2201 Interest of corporation controlled by you
Zhao Yin Jin Rong Kong Gu Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Shang Yin Xing Gu Fen You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Jin Rong Kong Gu You Xian Gong Si 2201 Interest of corporation controlled by you
Zhao Yin Guo Ji Zi Ben Guan Li Shen Zhen You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Shi Bei Lun Qu Guo You Zi Ben Yun Ying You Xian Gong Si 2201 Interest of corporation controlled by you
Ning Bo Bao Shui Qu Kong Gu You Xian Gong Si 2101 Beneficial owner
Chang Wei 2201 Interest of corporation controlled by you
Wang Aijun 2201 Interest of corporation controlled by you
China Merchants Bank Co., Ltd. 2201 Interest of corporation controlled by you
Zhang Kuo 2201 Interest of corporation controlled by you
Zhang Chong 2201 Interest of corporation controlled by you

AIM Vaccine Co Headlines

No Headlines